Colorectal Cancer Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Colorectal Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Sep 13, 2018

---

• Are We Being Misled About Precision Medicine?  
  L Szabo, New York Times, September 11, 2018
• Diagnostics of Pleiotropy in Mendelian Randomization Studies: Global and Individual Tests for Direct Effects.  
  Dai James Y et al. American journal of epidemiology 2018 Sep
• RAS-expanded Mutations and HER2 Expression in Metastatic Colorectal Cancer: A New Step of Precision Medicine.  
  Valentini Anna M et al. Applied immunohistochemistry & molecular morphology : AIMM 2018 Sep 26(8) 539-544
• Cancer Risks for PMS2-Associated Lynch Syndrome.  
  Ten Broeke Sanne W et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Aug JCO2018784777
• Family History and Cancer
  CDC Division of Cancer Control and Prevention, 2018
• Liquid Biopsy 'Weather Forecast' Can Predict When Tumors Will Return  
  V Forster, Forbes, August 30, 2018
• The Feelings About genomiC Testing Results (FACToR) Questionnaire: Development and Preliminary Validation.  
  Li Meng et al. Journal of genetic counseling 2018 Sep
• Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death.  
  Hieronymus Haley et al. eLife 2018 Sep 7
• When Should You Be Screened for Colorectal Cancer?
  S Bowen et al, CDC Blog Post, August 30, 2018
• Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition.  
  Fabrizio David A et al. Journal of gastrointestinal oncology 2018 Aug 9(4) 610-617